5757-85-7 Usage
Uses
Used in Organic Synthesis:
5-Amino-1,3-dimethylindazole is used as a building block in organic synthesis for the creation of various chemical compounds. Its unique structure allows for the formation of diverse molecules with potential applications in different industries.
Used in Drug Development:
5-Amino-1,3-dimethylindazole is used as a starting material in drug development due to its potential biological activity. Its unique structure and properties may contribute to the discovery of new pharmaceutical compounds with therapeutic benefits.
Used in Pharmaceutical Industry:
5-Amino-1,3-dimethylindazole may have potential applications in the pharmaceutical industry, as its unique structure and properties could be harnessed to develop new drugs with specific therapeutic targets. Further research is needed to fully understand its potential uses and optimize its application in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 5757-85-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,5 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5757-85:
(6*5)+(5*7)+(4*5)+(3*7)+(2*8)+(1*5)=127
127 % 10 = 7
So 5757-85-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H13N3OS/c1-11(20)13-3-2-4-14(9-13)18-16-19-15(10-21-16)12-5-7-17-8-6-12/h2-10H,1H3,(H,18,19)
5757-85-7Relevant academic research and scientific papers
HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY
-
Paragraph 1247; 1249, (2015/11/16)
Heteroaryl pyridone and aza-pyridone compounds of Formula I are provided, where one or two of X, X, and Xare N, and including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I foranddiagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
